FI955730A0 - Lääkeaineen jakamiskoostumus alfa-adeno-reseptoreita estäville aineille - Google Patents

Lääkeaineen jakamiskoostumus alfa-adeno-reseptoreita estäville aineille

Info

Publication number
FI955730A0
FI955730A0 FI955730A FI955730A FI955730A0 FI 955730 A0 FI955730 A0 FI 955730A0 FI 955730 A FI955730 A FI 955730A FI 955730 A FI955730 A FI 955730A FI 955730 A0 FI955730 A0 FI 955730A0
Authority
FI
Finland
Prior art keywords
drug
release
alpha
composition
drug delivery
Prior art date
Application number
FI955730A
Other languages
English (en)
Swedish (sv)
Other versions
FI955730A (fi
Inventor
Lisbeth Illum
Peter Watts
Nidal Farraj
Original Assignee
Danbiosyst Uk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danbiosyst Uk filed Critical Danbiosyst Uk
Publication of FI955730A0 publication Critical patent/FI955730A0/fi
Publication of FI955730A publication Critical patent/FI955730A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI955730A 1993-05-29 1995-11-28 Lääkeaineen jakamiskoostumus alfa-adeno-reseptoreita estäville aineille FI955730A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939311191A GB9311191D0 (en) 1993-05-29 1993-05-29 Controlled release drug formulation
PCT/GB1994/001158 WO1994027582A1 (en) 1993-05-29 1994-05-27 A drug delivery composition for alpha-adreno receptor blocking agents

Publications (2)

Publication Number Publication Date
FI955730A0 true FI955730A0 (fi) 1995-11-28
FI955730A FI955730A (fi) 1996-01-26

Family

ID=10736382

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955730A FI955730A (fi) 1993-05-29 1995-11-28 Lääkeaineen jakamiskoostumus alfa-adeno-reseptoreita estäville aineille

Country Status (12)

Country Link
EP (1) EP0700285B1 (fi)
JP (1) JPH09504779A (fi)
AT (1) ATE171370T1 (fi)
AU (1) AU684786B2 (fi)
CA (1) CA2163340A1 (fi)
DE (1) DE69413534T2 (fi)
DK (1) DK0700285T3 (fi)
ES (1) ES2124889T3 (fi)
FI (1) FI955730A (fi)
GB (2) GB9311191D0 (fi)
NO (1) NO306759B1 (fi)
WO (1) WO1994027582A1 (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6166024A (en) 1995-03-30 2000-12-26 Mayo Foundation For Medical Education And Research Use of topical azathioprine and thioguanine to treat colorectal adenomas
FR2752737B1 (fr) * 1996-08-29 1998-10-02 Synthelabo Comprime a liberation controlee de chlorhydrate d'alfuzosine
US6149940A (en) * 1996-08-29 2000-11-21 Synthelabo Tablet with controlled release of alfuzosine chlorhydrate
UA74141C2 (uk) 1998-12-09 2005-11-15 Дж.Д. Сірл Енд Ко. Фармацевтична композиція на основі тонкоподрібненого еплеренону (варіанти), спосіб її одержання та спосіб лікування розладів, опосередкованих альдостероном (варіанти)
US6749867B2 (en) 2000-11-29 2004-06-15 Joseph R. Robinson Delivery system for omeprazole and its salts
FR2820318B1 (fr) * 2001-02-08 2005-12-23 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant un principe actif et comprime obtenu
FR2820319B3 (fr) * 2001-02-08 2003-12-05 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant de l'alfuzosine et comprime obtenu
EP1366761A4 (en) * 2001-02-13 2004-04-21 Taisho Pharmaceutical Co Ltd GEL PREPARATIONS FOR INTERNAL USE
BR0315569A (pt) * 2002-10-22 2005-08-30 Ranbaxy Lab Ltd Apresentação farmacêutica de liberação prolongada contendo alfuzosina
WO2007080509A2 (en) 2006-01-12 2007-07-19 Wockhardt Ltd Sustained release compositions of alfuzosin
US20070292505A1 (en) * 2006-06-15 2007-12-20 Abrika Pharmaceuticals, Inc. Controlled release alfuzosin hydrochloride formulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1101649B (it) * 1978-12-15 1985-10-07 Lehner Ag Composizione farmaceutica ad azione prolungata contenente acidi biliari
FR2477015A1 (fr) * 1980-03-03 1981-09-04 Fabre Sa Pierre Composition pharmaceutique a base d'un alcaloide de l'ergot de seigle, a activite regulatrice sur le tonus vasculaire
US4931285A (en) * 1988-04-28 1990-06-05 Alza Corporation Aqueous based pharmaceutical coating composition for dosage forms
DE3822095A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
GB9523191D0 (en) 1996-01-17
DK0700285T3 (da) 1999-02-15
EP0700285B1 (en) 1998-09-23
GB2292315A (en) 1996-02-21
JPH09504779A (ja) 1997-05-13
NO306759B1 (no) 1999-12-20
EP0700285A1 (en) 1996-03-13
GB9311191D0 (en) 1993-07-14
ES2124889T3 (es) 1999-02-16
DE69413534T2 (de) 1999-03-18
FI955730A (fi) 1996-01-26
GB2292315B (en) 1997-04-02
ATE171370T1 (de) 1998-10-15
CA2163340A1 (en) 1994-12-08
WO1994027582A1 (en) 1994-12-08
DE69413534D1 (de) 1998-10-29
AU684786B2 (en) 1998-01-08
NO954583D0 (no) 1995-11-14
AU6802094A (en) 1994-12-20
NO954583L (no) 1995-11-14

Similar Documents

Publication Publication Date Title
EE9700241A (et) Farmatseutiline kompositsioon transdermaalseks manustamiseks
FI954228A (fi) Infuusiolaite hoitoaineen jaksottaista tai jatkuvaa antamista varten
FI955730A0 (fi) Lääkeaineen jakamiskoostumus alfa-adeno-reseptoreita estäville aineille
PT984774E (pt) Microesferas de libertacao controlada, com retencao gastrica, para uma administracao de drogas melhorada
DE69427472D1 (de) Arzneimittel mit kontrollierter Wirkstoffabgabe
FI954767A (fi) Lipofiilisiä lääkeaineita sisältävä farmaseuttinen koostumus
FI962154A0 (fi) Koostumus terapeuttisten tuotteiden in vivo valmistusta varten
NO953278D0 (no) Fremgangsmåter for in vivo-levering av biologisk aktive stoffer og sammensetninger som er nyttige for dette
NL300258I1 (nl) Farmaceutische samenstelling voor toepassing in debehandeling van diabetes.
ATE203161T1 (de) Polymer umhüllte tablette enthaltend amoxicillin und clavulanat
NO961136D0 (no) Farmasöytisk formuleringsgrunnlag for nano-suspensjoner
ID29994A (id) Komposisi farmasi untuk melawan ccr5 terdiri dari turunan anilida
NO20006630D0 (no) Farmasöytisk sammensetning for behandlingen av diabetes
PT1028707E (pt) Formulacoes oftalmicas de libertacao controlada contendo medicamentos soluveis em agua
DE69832816D1 (de) Orale pharmazeutische dosierungsform mit verlängerter wirkstofffreisetzung
DE60233898D1 (de) Transdermales therapeutisches system für parkinson-krankheit mit hohen rotigotin-plasmaspiegeln
PT1017392E (pt) Formulacao de medicamento com libertacao controlada do principio activo
NL193820B (nl) Vaste farmaceutische doseringsvorm voor orale toediening van Ibuprofen.
DE69920418D1 (de) Arzneimittel gegen hepatitis
FR2735132B1 (fr) Medicament polypeptidique modifie, composition et dispositif d'administration par electrotransport le contenant
AU3690495A (en) Pharmaceutical composition containing derivatives of sex hormones
ATE233106T1 (de) Stabile radioaktive medikamente
ZA984649B (en) "Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes".
PL301249A1 (en) Application of iphosphamide as an anticarcinogenic drug
DK0872238T3 (da) Anvendelse af olanzapin til fremstilling af et medikament til neuroprotektin

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: SYNTHELABO